Solventum Co. (NYSE:SOLV) Shares Sold by Creative Planning

Creative Planning decreased its holdings in Solventum Co. (NYSE:SOLV) by 11.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 26,627 shares of the company’s stock after selling 3,319 shares during the quarter. Creative Planning’s holdings in Solventum were worth $1,856,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Mather Group LLC. purchased a new position in Solventum during the 3rd quarter worth approximately $27,000. EverSource Wealth Advisors LLC purchased a new position in Solventum during the 1st quarter worth approximately $30,000. Hollencrest Capital Management purchased a new position in Solventum during the 2nd quarter worth approximately $25,000. Deseret Mutual Benefit Administrators purchased a new position in Solventum during the 2nd quarter worth approximately $25,000. Finally, Richard W. Paul & Associates LLC purchased a new position in Solventum during the 2nd quarter worth approximately $26,000.

Analyst Ratings Changes

Several equities analysts have weighed in on SOLV shares. Stifel Nicolaus started coverage on shares of Solventum in a research report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective on the stock. Wolfe Research started coverage on shares of Solventum in a research report on Thursday, September 26th. They set a “peer perform” rating on the stock. Piper Sandler started coverage on shares of Solventum in a research note on Monday, October 7th. They set a “neutral” rating and a $71.00 target price for the company. BTIG Research started coverage on shares of Solventum in a research note on Thursday, September 5th. They set a “neutral” rating for the company. Finally, Morgan Stanley decreased their target price on shares of Solventum from $70.00 to $55.00 and set an “equal weight” rating for the company in a research note on Monday, July 15th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Solventum has a consensus rating of “Hold” and a consensus target price of $64.33.

Solventum Stock Performance

SOLV stock opened at $73.36 on Tuesday. The company has a quick ratio of 0.96, a current ratio of 1.31 and a debt-to-equity ratio of 2.90. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05. The company has a fifty day simple moving average of $67.86 and a 200 day simple moving average of $61.33.

Solventum (NYSE:SOLV) last released its quarterly earnings data on Thursday, August 8th. The company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.10. The business had revenue of $2.08 billion during the quarter, compared to analyst estimates of $2.05 billion. The firm’s revenue was up .2% on a year-over-year basis. As a group, research analysts expect that Solventum Co. will post 6.38 EPS for the current fiscal year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.